HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genome-wide association study identifies loci associated with liability to alcohol and drug dependence that is associated with variability in reward-related ventral striatum activity in African- and European-Americans.

Abstract
Genetic influences on alcohol and drug dependence partially overlap, however, specific loci underlying this overlap remain unclear. We conducted a genome-wide association study (GWAS) of a phenotype representing alcohol or illicit drug dependence (ANYDEP) among 7291 European-Americans (EA; 2927 cases) and 3132 African-Americans (AA: 1315 cases) participating in the family-based Collaborative Study on the Genetics of Alcoholism. ANYDEP was heritable (h 2 in EA = 0.60, AA = 0.37). The AA GWAS identified three regions with genome-wide significant (GWS; P < 5E-08) single nucleotide polymorphisms (SNPs) on chromosomes 3 (rs34066662, rs58801820) and 13 (rs75168521, rs78886294), and an insertion-deletion on chromosome 5 (chr5:141988181). No polymorphisms reached GWS in the EA. One GWS region (chromosome 1: rs1890881) emerged from a trans-ancestral meta-analysis (EA + AA) of ANYDEP, and was attributable to alcohol dependence in both samples. Four genes (AA: CRKL, DZIP3, SBK3; EA: P2RX6) and four sets of genes were significantly enriched within biological pathways for hemostasis and signal transduction. GWS signals did not replicate in two independent samples but there was weak evidence for association between rs1890881 and alcohol intake in the UK Biobank. Among 118 AA and 481 EA individuals from the Duke Neurogenetics Study, rs75168521 and rs1890881 genotypes were associated with variability in reward-related ventral striatum activation. This study identified novel loci for substance dependence and provides preliminary evidence that these variants are also associated with individual differences in neural reward reactivity. Gene discovery efforts in non-European samples with distinct patterns of substance use may lead to the identification of novel ancestry-specific genetic markers of risk.
AuthorsLeah Wetherill, Dongbing Lai, Emma C Johnson, Andrey Anokhin, Lance Bauer, Kathleen K Bucholz, Danielle M Dick, Ahmad R Hariri, Victor Hesselbrock, Chella Kamarajan, John Kramer, Samuel Kuperman, Jacquelyn L Meyers, John I Nurnberger Jr, Marc Schuckit, Denise M Scott, Robert E Taylor, Jay Tischfield, Bernice Porjesz, Alison M Goate, Howard J Edenberg, Tatiana Foroud, Ryan Bogdan, Arpana Agrawal
JournalGenes, brain, and behavior (Genes Brain Behav) Vol. 18 Issue 6 Pg. e12580 (07 2019) ISSN: 1601-183X [Electronic] England
PMID31099175 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2019 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.
Topics
  • Black or African American (genetics)
  • Chromosomes, Human, Pair 13 (genetics)
  • Chromosomes, Human, Pair 3 (genetics)
  • Genetic Loci
  • Humans
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Reward
  • Substance-Related Disorders (ethnology, genetics, physiopathology)
  • Ventral Striatum (physiopathology)
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: